Scott Lucas, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Oklahoma City, OKNPI 1407843485
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,340 of the $3,130 with a category attached, or 74.8%. 10 manufacturers reported payments, led by Atricure, Inc. at 41.4% of the total. Reporting peaked in 2023 at $1,222 and has fallen 83.8% since, to $198 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in OK, where the typical reported total is $3,130.
Across 40 payments — averaging $78.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$1K
- Abiomed$578
- Medtronic$533
- Abbott$480
- W. L. Gore & Associates, Inc.$77
- Endologix LLC$73
- plus $94 from 4 others
What the payments were for
- Travel & lodging$79025%
- Food & beverage$2,34075%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 8 | $1,296 |
| Abiomed | 7 | $578 |
| Medtronic(2 entities) | 9 | $533 |
| Abbott | 7 | $480 |
| W. L. Gore & Associates, Inc. | 3 | $77 |
| Endologix LLC | 2 | $73 |
| Penumbra, Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $28 |
| Edwards Lifesciences | 1 | $19 |
| Cook Medical LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$930
- Impella$508
- ENDURANT IIS$171
- Connect HF$167
- AVEIR$150
- ATRICLIP LAA EXCLUSION SYSTEM$148
- GALLANT$147
How this compares
$3,130 in reported general payments places this provider in the 50th percentile of 48 thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $279 |
| Ondansetron Hcl | 20 | $158 |
| Warfarin Sodium | 14 | $106 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Oklahoma City
- James LongOklahoma City$634K
- Charles ElkinsOklahoma City$42K
- James ReinersmanOklahoma City$40K
- David VanhooserOklahoma City$25K
- Michael CannonOklahoma City$18K
- Daniel FrenoOklahoma City$16K
- Jess SchwartzOklahoma City$16K
- Marshall BellOklahoma City$14K
- Steven MillerOklahoma City$7K
- Jess ThompsonOklahoma City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.